Design, Synthesis, and In Vitro and In Vivo Biological Studies of a 3′-Deoxythymidine Conjugate that Potentially Kills Cancer Cells Selectively

Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth

(2011) Xing-Qi Li et al.   CANCER LETTERS

3′-(1,2,3-Triazol-1-yl)-3′-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure–activity investigations

(2010) Jay Lin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

(2010) B Sangro et al.   CANCER GENE THERAPY

Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage

(2010) Yen-Ling Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

(2010) Ying-Chun Shen et al.   JOURNAL OF GASTROENTEROLOGY

3′-[4-Aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine Analogues as Potent and Selective Inhibitors of Human Mitochondrial Thymidine Kinase

(2010) Sara Van Poecke et al.   JOURNAL OF MEDICINAL CHEMISTRY

Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway

(2009) Yu-Xiong Feng et al.   HEPATOLOGY

Mixed Inhibition of P450 3A4 as a Chemoprotective Mechanism against Aflatoxin B1-Induced Cytotoxicity withcis-Terpenones

(2008) Qibing Zhou et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4'-Thio-2'-Deoxyuridine

(2008) A. Morgenroth et al.   CLINICAL CANCER RESEARCH

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors

(2008) R. F. Barth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA